CRA economists advised counsel to Novartis throughout reviews of its three-part, $23 billion merger with GlaxoSmithKline. With the divestment of certain oncology drugs, the EC and FTC determined the deal would not hinder innovation and the development of new oncology drugs. CRA also advised Novartis on the sale of its animal health business to Eli Lilly.

CRA economists assisted Postmedia and Quebecor Media (QMI) throughout a review by the Competition Bureau. Ultimately, the agency decided not to challenge Postmedia’s $305.5 million acquisition of QMI’s English-language newspapers noting it is unlikely to lessen competition for advertising or readership in areas of overlap.

CRA economists advised counsel to Office Depot throughout a review by the US Federal Trade Commission (FTC) of its proposed $1.2 billion merger with OfficeMax. The FTC ultimately closed its Second Request investigation, noting that the merger is unlikely to lessen competition in the sale of consumable office supplies.

Antitrust and Competition

Antitrust & Competition Economics

CRA's competition economists have provided economic analysis and testimony in numerous competition matters in the United States, Europe, Australia, and Canada. Many have served in government antitrust agencies or are members of premier academic economics and law faculties.

Our experience extends to many industries, including, among others, healthcare, energy, computer hardware/software, retailing, telecommunications, aerospace and defense, entertainment, transportation, natural resources, sports, chemicals, pharmaceuticals, financial services, and consumer products.